RecruitingNot ApplicableNCT06262464
An OCD Prevention Programme for at Risk Adults
The Efficacy of an OCD Prevention Programme for at Risk Adults: a Randomized Clinical Trial
Sponsor
Babes-Bolyai University
Enrollment
200 participants
Start Date
Feb 9, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria1
- \- age over 18
Exclusion Criteria4
- clinically diagnosed OCD
- current psychiatric/psychotherapeutic treatment
- personality disorder diagnosis
- suicidal ideation
Interventions
BEHAVIORALPrevention
A cognitive-behavioural prevention programme.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06262464
Related Trials
A Multicenter Pediatric Deep Brain Stimulation Registry
NCT065856181 location
Pilot Study of RR-HNK in OCD
NCT065750751 location
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
NCT057838171 location
Neurostimulation Versus Therapy for Problems With Emotions
NCT057120571 location
University of Iowa Interventional Psychiatry Service Patient Registry
NCT044809181 location